Page last updated: 2024-08-22

stavudine and Non-alcoholic Fatty Liver Disease

stavudine has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayyash, M; Cohen, M; Ehrlich, A; Ioannidis, K; Nahmias, Y; Note, R; Ouedraogo, G; Riu, A; Tsytkin-Kirschenzweig, S; Vanfleteren, J1
Bauerfeind, R; Behrens, GM; Binz, A; Leverkus, M; Panayotova-Dimitrova, D; Stankov, MV; Vondran, FW1

Other Studies

2 other study(ies) available for stavudine and Non-alcoholic Fatty Liver Disease

ArticleYear
Microphysiological flux balance platform unravels the dynamics of drug induced steatosis.
    Lab on a chip, 2018, 08-21, Volume: 18, Issue:17

    Topics: Cell Line; Hepatocytes; Humans; Lab-On-A-Chip Devices; Metabolic Flux Analysis; Non-alcoholic Fatty Liver Disease; Stavudine; Valproic Acid

2018
Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation.
    AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16

    Topics: Anti-HIV Agents; Autophagy; Blotting, Western; Cells, Cultured; DNA, Mitochondrial; Fatty Liver; Female; Flow Cytometry; Hep G2 Cells; HIV Infections; Humans; Lipid Metabolism; Male; Microscopy, Electron; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Stavudine; Thymidine; Zidovudine

2012